[1]尹志辉,周志伟a,刘继勇a,等.乳腺癌患者组织多项组化标记物与血清CA153,CA125,CEA,25-OH-D3水平关联性分析模型建立及在预后判断的临床价值[J].现代检验医学杂志,2019,34(03):47-50，54.[doi:10.3969/j.issn.1671-7414.2019.03.011]
　YIN Zhi-hui,ZHOU Zhi-weia,LIU Ji-yonga,et al.Establishment of A Correlation Analysis Model betweenMulti-group Markers and Serum CA153,CA125,CEA,25-OH-D3in Breast Cancer Patients and Clinical Value in Prognosis[J].Journal of Modern Laboratory Medicine,2019,34(03):47-50，54.[doi:10.3969/j.issn.1671-7414.2019.03.011]
点击复制

乳腺癌患者组织多项组化标记物与血清CA153,CA125,CEA,25-OH-D3水平关联性分析模型建立及在预后判断的临床价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第34卷
期数:
2019年03期
页码:
47-50，54
栏目:
论著
出版日期:
2019-06-20

文章信息/Info

Title:
Establishment of A Correlation Analysis Model betweenMulti-group Markers and Serum CA153,CA125,CEA,25-OH-D3in Breast Cancer Patients and Clinical Value in Prognosis
文章编号:
1671-7414(2019)03-047-05
作者:
尹志辉1; 周志伟2a; 刘继勇2a; 杨保昌2a; 王凌凌2b
(1.邢台市第三医院检验科,河北邢台 054000; 2.中国石油天然气集团公司中心医院a.检验科; b.肿瘤科,河北廊坊 065000)
Author(s):
YIN Zhi-hui1; ZHOU Zhi-wei2a; LIU Ji-yong2a; YANG Bao-chang2a; WANG Ling-ling2b
(1.Department of Clinical Laboratory,Xingtai Third Hospital,Hebei Xingtai054000,China; 2a.Department of Clinical Laboratory; 2b.Department of Oncology,the Central Hospital of China National Petroleum Corporation,Hebei Langfang 065000,China)
关键词:
乳腺癌组化标记物;  肿瘤标记物;  糖类抗原153;  糖类抗原125;  25-羟基维生素D3;  关联性模型
分类号:
R737.9; R730.43
DOI:
10.3969/j.issn.1671-7414.2019.03.011
文献标志码:
A
摘要:
目的 探讨并建立乳腺癌患者组织多项组化标记与血清CA153,CA125,CEA,25-OH-D3水平关联性分析模型,评估模型在预后判断中的临床价值。方法 选取2016年1月～4月在中国石油天然气集团公司中心医院就诊的由组织病理学确诊的新发乳腺癌患者60例作为乳腺癌组,选取乳腺良性疾病患者60例作为乳腺良性疾病组,检测患者肿瘤标记物(CA153,CA125,CEA)和25-OH-D3; 对所有检测数据建立Apriori模型,对各检验指标与不同组化组合阳性乳腺癌间的关联性分析,并进行特征规则集分析,搜集30例首次就诊患者作为验证组,获取模型性能评估信息。结果①乳腺癌组的CEA和CA125水平均高于乳腺良性疾病组,而25-OH-D3水平则低于乳腺良性疾病组,差异均具有统计学意义(t=3.347,2.790,6.727,均P<0.05); CA153水平在乳腺癌组和乳腺良性疾病组间进行比较,差异无统计学意义(t=-0.054,P>0.05); ②乳腺癌组多项组化指标间关联性分析结果,预后较好指标组合分别为ER,PR和KiF67; PR和ER; ER,EFcadherin和KiF67,实验室指标预测变量分别为是否绝经,CA125水平,25-OH-D3水平和CEA水平; 预后较差指标组合为CFerbBF2和KiF67; Calponin和KiF67; PF63和KiF67,实验室指标预测变量分别为CA153水平,25-OH-D3水平,年龄和是否绝经; ③不同组合之间灵敏度分别为85.00%,77.78%,94.74%,88.89%,100.00%和65.00%; 特异度分别为54.54%,76.92%,58.33%,50.00%,50.00%和72.73%; 阳性预测值分别为77.27%,82.35%,78.26%,92.31%,89.29%和81.25%; 阴性预测值分别为66.67%,71.43%,87.50%,40.00%,100.00%和53.33%。结论 乳腺癌确诊患者其病理组化结果与血清CA153,CA125,CEA,25-OH-D3水平关联度较高,规则集在预测组化结果方面灵敏度高、特异度好,在患者预后中意义重大,具有临床应用价值。
Abstract:
Objective To explore and establish a correlation analysis model between multi-grouped markers of breast cancer patients and serum CA153,CA125,CEA,25-OH-D3 levels,and evaluate the clinical value ofthe model in prognosis.Methods Sixty patients with newly diagnosed breast cancer diagnosed by histopathology at the China National Petroleum Corporation Central Hospital from January to April 2016 were selected,andthe tumor markers(CA153,CA125,CEA)and 25-OH-D3 were also tested.Apriorimodel was established for all test data,and the correlation analysis between each test index and different grouped positive breast cancer was performed,and characteristic rule set analysis was performed.30 cases of first-time patients were collected as verification group to obtain model performance.Results ①The CEA and CA125 levels in the breast cancer group were higher than those in the benign breast disease group,while the 25-OH-D3 level waslower than that in the benign breast disease group(t=3.347,2.790,6.727,all P<0.05).The CA153 level was in breast cancer patients.Compared withthe benign breast disease group,the difference was not statistically significant(t=-0.054,P>0.05).②The correlation analysis between the multi-grouped indicators of breast cancer patients was ranked according to the confidence level from high to low,and the prognosis was better.The index combinations wereER,PR and KiF67,PR and ER,ER,EFcadherin and KiF67,with confidence levels of 100%,97.509% and 97.509%,respectively.The combination of poor prognosis indicators were CFerbBF2 and KiF67,Calponin and KiF67,PF63 and KiF67,with confidence levels of 96.000%,95.833% and 95.455%,respectively.③The sensitivitybetween different combinations were 85.00%,77.78%,94.74%,88.89%,100.00% and 65.00% respectively.The specificity were 54.54%,76.92%,58.33%,50.00%,50.00% and 72.73% respectively.The positive predictive values were 77.27%,82.35%,78.26%,92.31%,89.29% and 81.25% respectively.The negative predictive values were 66.67%,71.43%,87.50%,40.00%,100.00% and 53.33%,respectively.Conclusion The pathological histological results of patients with breast cancer were highly correlated with serum CA153,CA125,CEA,and 25-OH-D3 levels.The rule set has high sensitivity and specificity in predicting histochemical results.

参考文献/References:

[1] OEFFINGER K C,ELIZABETH R,FONTHAM E T,et al.Breast cancer screening for women at average risk:2015 guideline update from the American cancersociety[J].JAMA,2015,314(15):1599-1614.
[2] US PREVENTIVE SERVICES TASK FORCE.Scre-ening for breast cancer:US.Preventive services task force recommendation statement[J].Ann Intern Med,2009,151(10):716-726.
[3] 宋小川,谢小军,任宏,等.乳腺癌免疫组化检测在乳腺癌患者诊治中的意义分析[J].现代生物医学进展,2013,13(29):5694-5696. SONG Xiaochuan,XIE Xiaojun,REN Hong,et al.The analysis of breastcancer immunohistochemistry detectioon in diagnosis and treatment of breast cancer patients[J].Progress in Modern Biomedicine,2013,13(29):5694-5696.
[4] 万军.血清肿瘤标记物CA153,CA125,CEA和HER-2联合检测在乳腺癌诊断中的价值[J].现代检验医学杂志,2018,33(6):119-121. WAN Jun.Value of combined detection of tumor ma-rks CA153,CA125,CEA and HER-2 in the diagnosis of breast cancer[J].Journal of Modern Laboratory Medicine,2018,33(6):92-94.
[5] 张志勇,陈从华,明炜,等.检测患者外周血清CEA,CA15-3水平在乳腺癌手术前后的价值研究[J].河北医药,2017,39(6):857-859,864. ZHANG Zhiyong,CHEN Conghua,MING Wei,et al.Clinical value of detection of serum levels of CEA and CA15-3 in peripheral blood of patients with breast cancer before and after surgery[J].Hebei Medical Journal,2017,39(6):857-859,864.
[6] 张晓洁,张美娟,张立涛,等.CEA,CA153,CYFRA-21-1,CRP联合检测在乳腺癌辅助诊断中的临床价值探讨[J].国际检验医学杂志,2017,38(23):3352-3354. ZHANG Xiaojie,ZHANG Meijuan,ZHANG Litao,et al.Clinical value ofcombined detection of CEA,CA153,CYFRA21-1 and CRP in the diagnosis of breastcancer[J].International Journal of Laboratory Medicine,2017,38(23):3352-3354.
[7] 武四美,文兆明,俞根.血清中维生素D、血钙的水平与乳腺癌的关系研究[J].江西医药,2017,52(4):323-325. WU Simei,WEN Zhaoming,YU Gen.Relationship between serum vitamin Dand serum calcium levels and breast cancer[J].Jiangxi Medical Journal,2017,52(4):323-325.

备注/Memo

备注/Memo:
基金项目:廊坊市科技支撑计划项目,编号:2016013025。 作者简介:尹志辉(1984-),男,本科,学士,主管检验师,从事临床检验工作,E-mail:www.yin.cn@163.com。 收稿日期:2019-03-07 修回日期:2019-04-03
更新日期/Last Update: 2019-06-20